Related by context. All words. (Click for frequent words.) 73 undergone hysterectomies 68 underwent hysterectomy 67 undergoing hysterectomy 66 oophorectomy 66 bilateral oophorectomy 66 undergone radical prostatectomy 66 premenopausal 66 nulliparous women 65 partial hysterectomy 65 polycystic ovary syndrome PCOS 65 hysterectomy 65 ovaries removed 64 irregular menstrual cycles 64 polycystic ovaries 64 preventive mastectomies 64 pre menopausal 64 ovaries surgically 63 undergone lumpectomy 63 underwent radical prostatectomy 63 endometriosis ovarian cysts 63 endometrial carcinoma 63 ovulatory cycles 63 radical hysterectomy 63 thromboembolisms 63 peritoneal cancer 62 prophylactic mastectomies 62 fibroids endometriosis 62 perimenopausal women 62 tibolone 62 lobular cancer 62 undergo mastectomy 62 Postmenopausal 62 undergone mastectomy 62 epithelial ovarian 62 undergone vasectomy 62 baseline mammogram 62 atypical hyperplasia 62 salpingo oophorectomy 62 undergone breast augmentation 62 undergo radical prostatectomy 62 post menopausal 61 abnormal pap smear 61 endometrial hyperplasia 61 premature menopause 61 undergoing IVF 61 premenopausal women 61 bilateral orchiectomy 61 abnormal Pap smear 61 testicular germ cell 61 undergo hysterectomy 61 pre eclamptic 61 operable breast cancer 61 abnormal mammogram 61 cancerous lumps 61 prescribed statins 61 symptomatic fibroids 61 lobular breast cancer 60 prophylactic mastectomy 60 tamoxifen therapy 60 undergone gastric bypass 60 difficulty conceiving 60 LHRH receptor positive 60 advanced epithelial ovarian 60 untreated metastatic pancreatic 60 postmenopausal 60 preventive mastectomy 60 recurrent metastatic 60 postmenopausal hormones 60 abdominal ultrasounds 60 lymph node removal 60 Adjuvant chemotherapy 60 BRCA mutation carriers 60 Ovary removal 60 abnormal pap smears 60 hormone pills 60 polycystic ovarian syndrome PCOS 60 prostates removed 60 oral contraceptive pills 60 recurrent miscarriages 60 invasive lobular carcinoma 60 benign breast 60 BRCA1 mutation carriers 60 hormone therapy estrogen 60 hormone therapy 60 ductal breast cancer 60 drank pomegranate juice 60 rediagnosed 59 orchiectomy 59 estrogen progestin combination 59 GnRH agonists 59 abnormal Pap test 59 abnormal uterine growths 59 underwent prostatectomy 59 abnormal mammograms 59 LNG IUS 59 precancerous polyp 59 menopausal hormone therapy 59 oral bisphosphonates 59 gastrectomy 59 drank decaffeinated coffee 59 ovariectomy 59 ovarian cervical 59 vaginal hysterectomy 59 partial mastectomy 59 postmenopausal hormone replacement 59 radioiodine therapy 59 metastatic adenocarcinoma 59 advanced neoplasia 59 mild gestational diabetes 59 ALND 59 Premenopausal 59 estradiol gel indicated 59 bowel polyps 59 induce ovulation 59 BRCA mutation 59 underwent lumpectomy 59 recurrent UTI 59 advanced adenoma 59 advanced adenomas 58 ovary transplants 58 nonmetastatic 58 contralateral breast 58 abnormal Pap smears 58 prior chemotherapy regimens 58 fibrocystic disease 58 Menopausal hormone therapy 58 invasive carcinoma 58 myomectomy 58 fallopian tube carcinoma 58 prostate TURP 58 histologically confirmed 58 hip BMD 58 ductal carcinomas 58 ovarian endometrial 58 BRCA2 mutations 58 endometrial cancers 58 abdominal hysterectomy 58 colon rectal 58 hysterectomies 58 BRCA gene mutations 58 osteopenic 58 nulliparous 58 polycystic ovarian syndrome 58 undergoing colonoscopy 58 hormone receptor negative 58 flutamide 58 Hormone supplements 58 axillary node 58 amenorrhoea 58 singleton pregnancy 58 intestinal polyps 58 recurrent atrial fibrillation 58 deep venous thromboses 58 VCUG 58 benign nodules 58 anal lesions 58 HIV seronegative 58 screening colonoscopy 58 Wyeth estrogen progestin 58 breast reconstructions 58 underwent CABG 58 folic acid supplement 58 bilateral prophylactic mastectomy 58 undergo lumpectomy 58 BRCA2 carriers 58 testicular tumors 58 tanned indoors 58 Netherlands Cohort Study 58 asymptomatic hypothyroidism 58 PREMPRO 58 underwent brachytherapy 58 spontaneous preterm delivery 58 untreated metastatic colorectal 57 ticlopidine 57 adjuvant radiotherapy 57 undergo bariatric surgery 57 pancreatic resection 57 advanced HER2 positive 57 axillary lymph nodes 57 cystectomy 57 cilostazol 57 unexplained infertility 57 adenomatous polyps 57 undergone mastectomies 57 AVODART 57 colon polyp 57 trouble conceiving 57 GnRH agonist 57 anovulatory infertility 57 Depo Provera injections 57 precancerous cervical 57 ovulation induction 57 uterine fibroid tumors 57 underwent bariatric surgery 57 Heavy menstrual bleeding 57 densest breasts 57 cancerous ovarian cyst 57 invasive lobular 57 finasteride Proscar 57 HER2 amplified 57 nonmelanoma skin cancers 57 stomachs stapled 57 histologically proven 57 subclinical hyperthyroidism 57 invasive ductal breast cancer 57 leiomyomas 57 cosmetic breast implants 57 seronegative 57 undergo prostate biopsy 57 thyrotropin levels 57 anthracycline taxane 57 chronic prostatitis 57 progesterone receptor negative 57 BRCA1 mutations 57 plus progestin hormone 57 RET PTC rearrangements 57 obstetric complications 57 thymectomy 57 obese postmenopausal 57 premenopausal breast cancer 57 polycystic 57 breast carcinoma 57 preoperative chemotherapy 57 haemorrhagic stroke 57 chorioamnionitis 57 thyroidectomy 57 ovarian hyperstimulation syndrome OHSS 57 basal cell skin 57 postoperative chemotherapy 57 polycystic ovary syndrome 57 mastectomy chemotherapy 57 overexpress HER2 57 stimulate ovulation 57 progestin pills 57 adrenal tumors 57 testosterone supplementation 57 genital lesions 57 endometrial thickness 57 postmenopausal breast cancer 57 Biopsies 57 #mg ATC 57 atypia 57 lenalidomide Revlimid R 56 pancreatic lung 56 caesarean delivery 56 genital ulcer disease 56 colorectal adenomas 56 intravenous bisphosphonates 56 core needle biopsy 56 gene BRCA2 56 gestational hypertension 56 acrylamide intake 56 Sexually active 56 endometrial cancer 56 basal cell nevus syndrome 56 polycystic ovary 56 menstruated 56 orchidectomy 56 perioperatively 56 polycystic ovarian disease 56 unexplained vaginal bleeding 56 metastatic dermatofibrosarcoma protuberans DFSP 56 cranial radiation 56 tamoxifen 56 bilateral mastectomy 56 Prostate Lung Colorectal 56 uterine cancers 56 ovarian colorectal 56 dependent neoplasia 56 Henrik Leffers 56 implant ruptures 56 cancerous polyp 56 lymphomas leukemias 56 Polycystic Ovary Syndrome 56 testicular cancers 56 lipid lowering therapy 56 postmenopausal hormone therapy 56 fewer uterine cancers 56 axillary nodes 56 impair fertility 56 precancerous cervical lesions 56 oral antidiabetic medication 56 uterine perforation 56 woman ovulates 56 radical mastectomies 56 pre cancerous polyps 56 cerebral microbleeds 56 primary hypercholesterolemia 56 basal cell cancers 56 axillary dissection 56 adjuvant radiation 56 Caesarean deliveries 56 transfusion syndrome 56 atypical ductal hyperplasia 56 estrogen receptor negative 56 BRCA gene mutation 56 PLX STROKE targeting 56 nadroparin 56 BRCA2 gene mutation 56 patients undergoing CABG 56 prostate glands 56 postmenopausal women 56 BRCA mutations 56 upper endoscopy 56 endometrial biopsy 56 parathyroidectomy 56 PAP smears 56 Subgroup analysis 56 venous thromboembolisms 56 Benign prostatic hyperplasia BPH 56 aromatase inhibitor therapy 56 undergoing radical prostatectomy 56 hydroxychloroquine 56 HER2 positive tumors 56 hysterectomies performed 56 venous thrombosis 56 prescribed antipsychotics 56 secondary amenorrhea 56 relapsed ALL 56 gestational diabetes mellitus 56 symptomatic BPH 56 exemestane 56 elevated CRP 56 primary ovarian insufficiency 56 hormone receptor status 56 artery embolization 56 preventative mastectomy 56 β blockers 56 breast cancer recurrence 56 mutated BRCA1 56 gallstone disease 56 axillary lymph node dissection 56 clomipramine 56 Endometrial ablation 56 androgen ablation 56 breast endometrial 56 conjugated equine estrogen 56 anastrazole 56 breast cancer recurrences 56 blocked fallopian tubes 56 Digital Mammographic Imaging 56 coronary blockages 56 recurrent VTE 56 undergoing bariatric surgery 56 total abdominal hysterectomy 56 dysfunctional voiding 56 HER2 positive cancers 56 Wactawski Wende 56 heavy menstrual bleeding 56 thyroid nodules 56 diethylstilbestrol DES 56 bladder cancers 56 cancerous breast 56 Premenopausal women 56 hyperplasia BPH 55 bowel cancers 55 adjuvant chemotherapy 55 fibroma 55 BRCA2 mutation carriers 55 beta carotene supplementation 55 folate supplementation 55 BRCA carriers 55 oral clodronate 55 recurrent miscarriage 55 hypopituitarism 55 dysentery bursitis 55 underwent surgical resection 55 PAP smear 55 oral contraceptive pill 55 singleton pregnancies 55 yearly mammogram 55 seroconverted 55 yearly mammograms 55 Prostate Specific Antigen PSA 55 % CI #.#-#.# [008] 55 postmenopausal hormone 55 recurrent bladder 55 normotensive 55 menstrual bleeding 55 metastatic HER2 positive 55 cranial irradiation 55 ambiguous genitalia 55 bilateral mastectomies 55 unexplained stillbirth 55 hypogonadal men 55 Femara letrozole 55 antiestrogen therapy 55 estrogen hormone therapy 55 Dr. Ashutosh Tewari 55 hormonal treatments 55 adenoma 55 mammographic density 55 chemoradiation therapy 55 adenotonsillectomy 55 undergo gastric bypass 55 ductal cancer 55 precancerous tumors 55 locoregional recurrence 55 valproate 55 post partum haemorrhage 55 breastfed exclusively 55 inconclusive Pap 55 ovulation inducing 55 sentinel node biopsy 55 normal karyotype 55 liver biopsies 55 atrophic vaginitis 55 conceiving naturally 55 invasive breast cancer 55 gallbladder disease 55 surgically induced 55 BRCA1 mutation 55 colorectum 55 biochemical relapse 55 placental malaria 55 removed laparoscopically 55 overt hypothyroidism 55 ectopic pregnancies 55 SHBG levels 55 Radical prostatectomy 55 retrograde ejaculation 55 perioperative complications 55 vulvar cancer 55 masectomy 55 benign proliferative breast 55 chemotherapy cisplatin 55 estrogen therapy 55 endometriosis 55 oocyte retrieval 55 hormonal therapy 55 nonpregnant women 55 pelvic prolapse 55 chlamydial infection 55 colorectal neoplasms 55 Uterine cancer 55 Mastectomies 55 HIV HCV coinfected 55 PGD PGS 55 bi lateral mastectomy 55 decompensated cirrhosis 55 untreated chlamydia 55 deletion 5q 55 estrogen pills 55 adjuvant hormonal therapy 55 vertebral fracture 55 vasomotor symptoms 55 nonvertebral fractures 55 polyp recurrence 55 catheter angiography 55 coronary arteriography 55 autoantibody positive 55 RYGB surgery 55 relapsed MM 55 molar pregnancy 55 Complication rates 55 clomiphene 55 ovarian cysts 55 lipid lowering drugs 55 menorrhagia 55 elevated hsCRP 55 overt hepatic encephalopathy HE 55 irregular menstrual periods 55 colorectal adenoma 55 gastro oesophageal reflux disease 55 plus progestin 55 nodal metastasis 55 dysplastic lesions caused 55 estrogen progestin therapy 55 parous women 55 neurogenic bladder 55 Dietary Modification Trial 55 ASPS statistics 55 weekly subcutaneous injections 55 metastatic gastric 55 underwent resection 55 liver transplant recipients 55 raloxifene Evista 55 HNSCC 55 Testosterone gel 55 bowel resection 55 Hurthle cell 55 loop diuretics 55 AstraZeneca Arimidex 55 thrombophilia 55 underwent radical cystectomy 55 hiatus hernia 55 BRAF gene mutations 55 retrospective cohort 55 placebo dexamethasone 55 anastrozole 55 faulty BRCA genes 55 antiandrogen 54 mutated K ras 54 irregular menstrual cycle 54 lymph node involvement 54 AML MDS 54 TDF FTC 54 Subgroup analyzes 54 metastatic lung cancer 54 egg retrieval 54 EBRT 54 elevated depressive symptoms 54 varicocele 54 cervical lesions 54 breast tenderness 54 tubal reversal 54 metastasized breast cancer 54 LYSTEDA 54 untreated AML 54 malignant lump 54 preterm newborns 54 PremPro 54 undergone FGM 54 antiandrogens 54 pCR 54 fallopian tube cancers 54 thyroid hormone levels 54 ICDs implanted 54 resectable pancreatic cancer 54 breast conserving lumpectomy 54 Prempro pills 54 CC genotype 54 undescended testes 54 alendronate Fosamax 54 oophorectomy removal 54 prescribe statins 54 nonhormonal 54 euthyroid 54 beta blocker therapy 54 underwent coronary angiography 54 underwent liver transplantation 54 epithelial ovarian cancer 54 monozygotic twin 54 immunosuppressive medications 54 ovary uterus 54 serum estradiol 54 coronary calcification 54 sentinel lymph node biopsy 54 spontaneous preterm birth 54 conceive naturally 54 malignant polyps 54 3TC lamivudine Epivir 54 hormone estradiol 54 prostate pancreatic 54 adenoma recurrence 54 anticoagulants blood thinners 54 cervixes 54 benign prostatic hypertrophy 54 Hormone pills 54 perforated colons 54 postmenopause 54 Screening Trial DMIST 54 abnormal cytology 54 IUD inserted 54 colorectal bowel 54 adenoidectomy 54 breast conserving 54 ovarian hyperstimulation 54 Gestational diabetes affects 54 methotrexate therapy 54 Schaffir 54 anovulatory 54 BRCA deficient 54 aneurysmal subarachnoid hemorrhage 54 levonorgestrel releasing 54 pelvic ultrasound 54 DHEA supplementation 54 undergone bariatric surgery 54 Shelley Salpeter 54 tamoxifen Nolvadex ® 54 cervical smears 54 lymph node biopsies 54 postmenopausal estrogen 54 anal cancers 54 Chlamydia infection 54 chewed sugarless gum 54 narcolepsy cataplexy 54 metastatic bladder 54 precancerous spots 54 androgen suppression 54 immunocompetent adults 54 prednisone steroid 54 osteoporotic fractures 54 shorter telomere length 54 CYP#D# inhibitor 54 NMIBC 54 citalopram Celexa 54 Health Initiative Observational 54 Paxil paroxetine 54 ano genital warts 54 gynecological examinations 54 autologous transplants 54 drug clomiphene 54 containing drospirenone 54 vitro fertilizations 54 underactive thyroid gland 54 colonscopy 54 hormonally sensitive 54 prescribed statin 54 preeclamptic 54 ejaculatory dysfunction 54 venlafaxine Effexor 54 tubal pregnancies 54 recurrent glioblastoma multiforme 54 primary peritoneal 54 orchitis 54 gynaecologic 54 colon tumors 54 azoospermia 54 aromatase inhibitor 54 colon perforation 54 accomplice Hudgens 54 uterus womb 54 screening mammogram 54 Intrauterine devices 54 postoperative complication 54 thyroid hormone replacement 54 precancerous condition 54 perimenopausal 54 hydroxyvitamin D levels 54 Dr Zorbas 54 Multivariate analyzes 54 Wilm tumor 54 ASCUS 54 prescribed Prozac 54 subfertility 54 severe renal impairment 54 radical retropubic prostatectomy 54 curable cancers 54 corticosteroid induced 54 neoadjuvant therapy 54 anthracycline chemotherapy 54 thromboembolic events 54 atrophic gastritis 54 thoracoscopic lobectomy 54 prophylactic oophorectomy 54 prostate biopsies 54 pilocytic astrocytoma 54 HIV uninfected 54 fibroid tumors 54 vasectomy reversal 54 oral antidiabetes 54 postoperative AF 54 tumor histology 54 antidepressant paroxetine 54 androgen deprivation 54 chemoradiation 54 BRCA2 mutation 54 prednisone prednisolone 54 menopausal symptom 54 Cesarean deliveries 54 recurrent ovarian 54 vasomotor symptoms associated 53 anti androgen 53 hMG 53 depot medroxyprogesterone acetate 53 combination estrogen progestin 53 olaparib 53 spine fractures 53 lipid lowering medication 53 DEAR MAYO CLINIC 53 noncancerous growths 53 mL/min/#.# m 2 53 menopausal hormone 53 uterus fallopian tubes 53 noninvasive outpatient 53 Androgenetic Alopecia 53 irinotecan chemotherapy 53 preventing genital warts 53 vitro maturation 53 biopsies 53 erectile difficulties 53 BRCA testing 53 aromatase inhibitors AIs 53 pravastatin therapy 53 pelvic lymphadenectomy 53 Folfox 53 underwent laparoscopic surgery 53 Endometrial 53 invasive prenatal 53 placenta praevia 53 recurrent DVT 53 thrombocytopenic 53 tonsil removal 53 prostate cancer CaP 53 transferrin saturation 53 esophageal resection 53 carotid artery blockage 53 highest tertile 53 nonhormonal drug 53 prescribe Paxil 53 colorectal neoplasia 53 Bevacizumab Avastin 53 pyridostigmine 53 lymph node biopsy 53 urolithiasis 53 breast asymmetry 53 elevated LDL cholesterol 53 abnormal lipid levels 53 collapse Betsy Sathers 53 antiretroviral naïve 53 Natazia 53 lipid lowering medications 53 irregular menses 53 chemoradiotherapy 53 osteosarcomas 53 rectal cancer 53 deliver vaginally 53 adenoid tissue 53 GBA mutations 53 Colon polyps 53 Cholesterol Levels SPARCL 53 breast uterine 53 adjuvant therapy 53 undergoing androgen deprivation 53 oral contraception 53 underarm lymph nodes 53 primary dysmenorrhea 53 postoperative complications 53 lifetime abstainers 53 ovarian function 53 nonischemic 53 ginkgo biloba extract 53 ovarian malignancy 53 Progestin 53 relieve menopausal symptoms 53 pelvic examinations 53 systemic corticosteroid 53 urinary bladder cancer 53 axillary node dissection 53 beta carotene supplements 53 Postmenopausal Women 53 sacrocolpopexy 53 prescribed antidepressants 53 metastatic ovarian cancer 53 valacyclovir 53 varicoceles 53 Kailas Gheewala 53 treat menopausal symptoms 53 Mofenson 53 abnormal pap tests 53 pelvic lymph nodes 53 ovarian stimulation 53 diagnosed prenatally 53 Carotid Revascularization Endarterectomy vs. 53 Swedish Mammography Cohort 53 cancer recurred 53 preoperative radiotherapy 53 radiotherapy chemotherapy 53 ICSI cycles 53 fibrocystic 53 mIU L 53 nonvertebral fracture 53 asymptomatic PAD 53 non anthracycline Taxotere 53 NATRECOR ® 53 Juvenile Idiopathic Arthritis 53 relapsed ovarian cancer 53 precocious puberty 53 non aspirin NSAIDs 53 premenstrual dysphoric disorder PMDD 53 nonfunctioning kidneys 53 neoadjuvant 53 vaginal estrogen 53 thyroid deficiency 53 Folic acid supplements 53 situ LCIS 53 Testosterone Therapy 53 pegylated liposomal doxorubicin 53 breast lumps 53 #q#.# deletion syndrome 53 stage IIIb IV 53 5-fluorouracil/leucovorin 53 hereditary breast cancer 53 limiting generalizability 53 conjugated estrogen 53 screening colonoscopies 53 alkylating agents 53 medroxyprogesterone acetate 53 Chescheir 53 slow metabolizers 53 ingested methadone 53 confidence interval #.#-#.# 53 hormone FSH 53 intrauterine insemination IUI 53 hypogonadal 53 beta estradiol 53 benign polyps 53 folic acid intake 53 congenital toxoplasmosis 53 underactive thyroids 53 Klinefelter syndrome 53 Cystectomy 53 % CI #.#-#.# [003] 53 Statin therapy 53 cisplatin chemotherapy 53 SLNB 53 neurodevelopmental impairment 53 reoperations 53 intrauterine insemination 53 postoperative mortality 53 Viread Emtriva 53 benign noncancerous 53 preeclamptic women 53 nonmelanoma 53 cryptorchidism 53 polycystic kidneys 53 prostate carcinoma 53 progestogen 53 specific antigen PSA 53 subclinical hypothyroidism 53 iniparib BSI 53 asymptomatic carotid stenosis 53 menstrual irregularity 53 Tamoxifen 53 peripartum cardiomyopathy 53 Contraceptive pills 53 lobular carcinoma 53 conjugated equine estrogens 53 antihypertensive therapy 53 corticosteroid therapy 53 transabdominal 53 dalteparin 53 diverticular bleeding 53 IM progesterone 53 spontaneously aborted 53 low ptau levels 53 hormonally responsive 53 renal transplants 53 antenatal depression 53 cancerous polyps 53 hormonal contraception 53 paclitaxel cisplatin 53 multivariable adjusted 53 progestin therapy 53 angioplasties stents 53 progestins 53 hypokalemia hypomagnesemia 53 taxane therapy 53 T1DM 53 endogenous estrogen 53 nonfasting triglyceride levels 53 premature ovarian 53 Sexual dysfunction 53 cancerous testicle 53 serum IGF 53 BRIP1 53 asthma rhinitis 53 mammographic screening 53 keloid scarring 53 HPV prevalence 53 hormonal therapies 53 letrozole Femara 53 postoperative morbidity 53 heterosexually acquired 53 laparoscopically assisted 53 Liver transplants 53 eribulin 53 uterine fibroid 53 female endoscopist 53 fasting triglyceride levels 53 esophagectomy 53 progestagen 53 chemo radiotherapy 53 sFlt 1 53 Cochrane reviewers 53 recurrent ovarian cancer 53 underwent breast augmentation 53 FOLFOX4 53 myelogenous leukemia 53 untreated celiac disease 53 seminoma 53 chemo therapy 53 IVF cycles 53 carotid stenosis 53 myelomeningocele 53 ovarian dysfunction 53 cutaneous melanoma 53 drank caffeinated 53 pre pubertal 53 bile duct cancers 53 seropositive 53 CVD mortality 53 hormones estrogen 53 lichen planus 53 #mg/day [001] 53 colorectal polyps 53 endarterectomy 53 cervical intraepithelial neoplasia 53 GH deficient 53 squamous histology 53 Wilms tumors 53 paricalcitol 53 liver biopsy 53 CIN3 53 TNF blocker therapy 53 uterine bleeding 53 Hilakivi Clarke 53 chronic HCV genotype 53 elevated triglyceride levels 53 ovarian uterine 53 got Abbott MitraClip 52 Hysterectomies 52 undergone gender reassignment 52 invasive cervical cancer 52 clodronate 52 undergoing tonsillectomy 52 graft occlusion 52 postoperative delirium 52 elevated ALT 52 faulty BRCA2 gene 52 intracranial haemorrhage 52 surgical biopsies 52 intractable epilepsy 52 cancerous prostates 52 ovarian hormones 52 prenatally exposed 52 carotid surgery 52 abdominally obese 52 undergoing coronary angiography 52 placebo dummy pill 52 engineered bladders 52 delaying childbirth 52 desire disorder HSDD 52 uterine tumors 52 mastectomy 52 overactive bladder symptoms 52 Hypoactive Sexual Desire Disorder 52 distant metastases 52 serodiscordant couples 52 TURP 52 dietary calcium intake 52 antireflux surgery 52 papillary renal cell carcinoma 52 perinatal complications 52 deep vein thromboses 52 adjunctive placebo 52 cT3 prostate cancer 52 shunning postmenopausal hormone 52 dietary questionnaires 52 nondiabetic patients 52 thromboembolic 52 Doxil ® 52 NNRTI resistance 52 hirsutism 52 colon adenomas 52 letrozole 52 bladder incontinence 52 menstrual abnormalities 52 Ewing sarcoma bone 52 fluoxetine Prozac 52 onset idiopathic hypogonadism 52 Amniocentesis 52 menstruate 52 adenomyosis 52 fragility fracture 52 SIDS infants 52 NOLVADEX 52 premenstrual syndrome PMS 52 performed laparoscopically 52 precancer 52 HMG CoA reductase inhibitors 52 therapy HRT 52 Disorder FSAD 52 carotid IMT 52 gynaecomastia 52 drospirenone containing 52 Tibolone 52 pneumonectomy 52 preterm deliveries 52 Follistim 52 Michael F. Leitzmann 52 leflunomide 52 colorectal polyp 52 reflux disease 52 uterus ovaries 52 androgen deprivation therapy 52 prolongs survival 52 total thyroidectomy 52 THIS STUDY 52 hormone receptor positive 52 ovary stimulating 52 advanced metastatic prostate 52 comorbidities 52 onset diabetes mellitus 52 urothelial cancer 52 undergoing chemo 52 laproscopic procedure 52 recurrent urinary tract infection 52 ALA PDT 52 folate intake 52 sex hormones androgens 52 relapsing remitting MS RRMS 52 WHIMS 52 statin therapy 52 penile vaginal intercourse 52 denser breasts 52 androgen deficiency 52 debulking surgery